Hepatitis B vaccine - Akela Pharma
Latest Information Update: 17 Dec 2021
At a glance
- Originator Nventa Biopharmaceuticals Corporation
- Developer Akela Pharma
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis B